https://old.journalforclinicalstudies.com/as-viatris-seeks-growth-in-eye-care-its-ocuphire-partnered-dilation-drop-ryzumvi-wins-fda-nod/ 2023-09-28T09:19:29+00:00 https://old.journalforclinicalstudies.com/in-emgality-patent-case-against-teva-lilly-wins-reversal-of-177m-verdict/ 2023-09-28T09:18:02+00:00 https://old.journalforclinicalstudies.com/we-cant-forget-about-this-as-chemotherapy-shortage-ebbs-and-flows-attention-shifts-to-long-term-solutions/ 2023-09-28T09:16:28+00:00 https://old.journalforclinicalstudies.com/as-rsv-vaccine-showdown-looms-pfizers-abrysvo-wins-cdc-blessing-for-maternal-protection/ 2023-09-28T09:14:49+00:00 https://old.journalforclinicalstudies.com/elrig-uk-establishes-engagement-strategy-work-group/ 2023-09-14T12:22:26+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/09/ELRIG-ESWG.png https://old.journalforclinicalstudies.com/bristol-myers-squibb-reports-results-from-phase-ii-study-of-bms-986278/ 2023-09-13T12:38:59+00:00 https://old.journalforclinicalstudies.com/pepromene-bio-concludes-first-dose-cohort-of-b-nhl-therapy-trial/ 2023-09-13T12:34:38+00:00 https://old.journalforclinicalstudies.com/nuvectis-pharma-kickstarts-phase-ia-trial-in-solid-tumours/ 2023-09-13T12:29:49+00:00 https://old.journalforclinicalstudies.com/altimmune-completes-dosing-in-momentum-trial-to-treat-obesity/ 2023-09-13T10:38:30+00:00 https://old.journalforclinicalstudies.com/replicate-bioscience-doses-first-patient-in-trial-of-rabies-vaccine/ 2023-09-13T09:46:25+00:00 https://old.journalforclinicalstudies.com/before-key-tagrisso-showdown-jj-notches-rybrevant-trial-win-in-large-lung-cancer-area/ 2023-09-07T09:29:06+00:00 https://old.journalforclinicalstudies.com/after-manufacturing-setback-at-fda-ascendis-strikes-150m-royalty-deal-on-its-first-commercial-drug/ 2023-09-07T09:27:42+00:00 https://old.journalforclinicalstudies.com/astrazeneca-hit-with-fda-rejection-for-ultomiris-in-rare-autoimmune-disorder/ 2023-09-07T09:24:31+00:00 https://old.journalforclinicalstudies.com/jjs-patient-assistance-program-suffers-data-breach-ibm-says/ 2023-09-07T09:21:46+00:00 https://old.journalforclinicalstudies.com/tower-continues-innovation-streak-with-new-product-launch-at-cphi-barcelona/ 2023-09-06T13:37:43+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/09/Tower-Cold-Chain-CPHI-scaled.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2023/09/Tower_Passive-temperature-controlled-container-range-Tower-Cold-Chain.jpg https://old.journalforclinicalstudies.com/fda-turns-down-outlooks-ophthalmic-version-of-roches-avastin-over-manufacturing-data-shortfalls/ 2023-08-31T09:38:53+00:00 https://old.journalforclinicalstudies.com/with-25k-donation-to-pence-pac-lilly-ceo-ricks-defies-some-of-companys-stated-positions/ 2023-08-31T09:37:41+00:00 https://old.journalforclinicalstudies.com/johnson-johnsons-spinoff-of-kenvue-provides-13-2b-in-potential-ma-firepower/ 2023-08-31T09:36:09+00:00 https://old.journalforclinicalstudies.com/amid-shortage-fda-clears-several-generics-of-takedas-popular-adhd-drug-vyvanse/ 2023-08-31T09:34:44+00:00 https://old.journalforclinicalstudies.com/after-1-7b-opioid-settlement-mallinckrodt-readies-2nd-bankruptcy-bid/ 2023-08-24T09:49:17+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-tapped-thermo-fisher-to-help-make-obesity-drug-wegovy-amid-catalent-woes-reuters/ 2023-08-24T09:47:27+00:00 https://old.journalforclinicalstudies.com/fda-blasts-exeltis-over-misleading-social-media-post-about-birth-control-drug/ 2023-08-24T09:38:03+00:00 https://old.journalforclinicalstudies.com/a-tale-of-2-industries-fdas-robert-califf-weighs-in-on-fundamental-problem-causing-so-many-shortages/ 2023-08-24T09:31:36+00:00 https://old.journalforclinicalstudies.com/csl-gets-top-line-boost-thanks-to-a-post-pandemic-boom-in-plasma-collections/ 2023-08-17T08:43:05+00:00 https://old.journalforclinicalstudies.com/doj-bashes-chamber-of-commerces-lawsuit-against-iras-medicare-price-negotiations/ 2023-08-17T08:41:58+00:00 https://old.journalforclinicalstudies.com/tevas-trial-in-high-stakes-kickbacks-case-delayed-as-company-pursues-rare-pretrial-appeal/ 2023-08-17T08:40:39+00:00 https://old.journalforclinicalstudies.com/the-ad-council-teams-up-with-the-alzheimers-association-for-hispanic-dementia-awareness-push/ 2023-08-17T08:36:15+00:00 https://old.journalforclinicalstudies.com/tower-cold-chain-accelerates-growth-with-two-new-senior-appointments/ 2023-08-08T14:46:00+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/08/Tower_Karin-Van-Den-Brekel-Regional-Commercial-Manager-EMEA-e1691504766960.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2023/08/Tower_Niall-Walsh-Business-Development-Manager-Ireland-e1691504818234.jpg https://old.journalforclinicalstudies.com/alkermes-nearing-oncology-split-posts-big-q2-sales-gain-after-winning-jj-arbitration-case/ 2023-07-27T08:29:17+00:00 https://old.journalforclinicalstudies.com/octapharma-secures-fda-nod-for-warfarin-reversal-agent-balfaxar/ 2023-07-27T08:28:00+00:00 https://old.journalforclinicalstudies.com/pre-launch-kol-talks-linked-to-1-5-time-boost-to-drug-uptake/ 2023-07-27T08:26:55+00:00 https://old.journalforclinicalstudies.com/eli-lilly-boehringer-ingelheims-jardiance-expands-reach-with-key-eu-nod-in-chronic-kidney-disease/ 2023-07-27T08:25:57+00:00 https://old.journalforclinicalstudies.com/lupin-gets-off-light-after-fda-inspection-at-indian-manufacturing-plant/ 2023-07-13T09:01:33+00:00 https://old.journalforclinicalstudies.com/fda-clears-more-chemotherapy-imports-from-chinas-qilu-amid-shortage-of-key-cancer-meds/ 2023-07-13T09:00:11+00:00 https://old.journalforclinicalstudies.com/merck-applies-more-pressure-against-ira-asking-for-decision-without-trial-in-fight-with-us-government/ 2023-07-13T08:58:52+00:00 https://old.journalforclinicalstudies.com/how-will-the-price-of-eisai-and-biogens-leqembi-impact-medicare-sen-sanders-wants-to-know/ 2023-07-13T08:57:40+00:00 https://old.journalforclinicalstudies.com/revvity-establishes-scientific-centre-of-excellence-for-genomic-insight-in-cambridge/ 2023-07-13T08:39:28+00:00 https://old.journalforclinicalstudies.com/shipping-clinical-trials-robustly-and-reliably/ 2023-07-07T12:42:37+00:00 https://old.journalforclinicalstudies.com/exploring-the-limb-girdle-muscular-dystrophy-clinical-trial-landscape-2/ 2023-07-07T12:39:53+00:00 https://old.journalforclinicalstudies.com/dispelling-doubt-effective-scientificjournalism-in-a-time-of-polarisation/ 2023-07-07T12:37:11+00:00 https://old.journalforclinicalstudies.com/ensuring-unbiased-oversight-the-case-for-independent-expert-committeemanagement/ 2023-07-07T12:30:58+00:00 https://old.journalforclinicalstudies.com/how-lilly-is-streamlining-regulatory-operations/ 2023-07-07T12:25:25+00:00 https://old.journalforclinicalstudies.com/whyzehealth/ 2023-07-07T12:22:28+00:00 https://old.journalforclinicalstudies.com/the-role-of-lims-in-supporting-iso-17025-accreditation/ 2023-07-07T12:13:53+00:00 https://old.journalforclinicalstudies.com/comparing-treatment-performance-through-evidence-synthesis/ 2023-07-07T12:10:30+00:00 https://old.journalforclinicalstudies.com/enhancing-healthcare-through-improved-patient-labeling/ 2023-07-07T12:06:54+00:00 https://old.journalforclinicalstudies.com/clinical-trial-technology-trends-the-top-5-innovations-shaping-clinical-trials-in-2023/ 2023-07-07T12:03:59+00:00 https://old.journalforclinicalstudies.com/design-and-conduct-of-trials-in-alzheimersdisease-following-the-impending-approvalsof-disease-modifying-agents/ 2023-07-06T13:30:05+00:00 https://old.journalforclinicalstudies.com/clinical-research-more-than-words/ 2023-07-06T13:29:31+00:00 https://old.journalforclinicalstudies.com/who-cares-about-diversity-in-clinical-trials/ 2023-07-06T13:28:51+00:00 https://old.journalforclinicalstudies.com/crm-study-coordinators-making-a-difference-in-clinical-trial-conduct-in-malaysia/ 2023-07-06T13:28:18+00:00 https://old.journalforclinicalstudies.com/developing-a-pre-ind-packing-strategy-toexpedite-clinical-trial-timelines/ 2023-07-06T13:27:23+00:00 https://old.journalforclinicalstudies.com/digital-clinical-trials-time-to-throw-out-theold-rule-book/ 2023-07-06T13:26:45+00:00 https://old.journalforclinicalstudies.com/next-level-clinical-trial-technology-canavoid-dropouts-and-accelerate-drugdevelopment/ 2023-07-06T13:26:03+00:00 https://old.journalforclinicalstudies.com/beyond-modernisation-unlocking-the-valueof-regulatory-information-management/ 2023-07-06T13:25:22+00:00 https://old.journalforclinicalstudies.com/the-year-ahead-for-life-sciences-regulatoryoperations/ 2023-07-06T13:24:34+00:00 https://old.journalforclinicalstudies.com/data-protection-and-clinical-trial/ 2023-07-06T13:23:03+00:00 https://old.journalforclinicalstudies.com/rethinking-statistical-significance-in-a-raredisease-context/ 2023-07-06T13:22:20+00:00 https://old.journalforclinicalstudies.com/the-role-of-confirmatory-trials-after-accelerated-approval/ 2023-07-06T13:21:29+00:00 https://old.journalforclinicalstudies.com/alkermes-rebuffs-challenge-from-activist-investor-sarissa-for-now/ 2023-07-06T08:27:02+00:00 https://old.journalforclinicalstudies.com/novartis-sells-off-dry-eye-disease-med-xiidra-other-ophthalmology-assets-to-bausch-lomb-for-2-5b/ 2023-07-06T08:25:02+00:00 https://old.journalforclinicalstudies.com/fujifilm-diosynth-taps-company-veteran-lars-petersen-to-drive-cdmo-toward-1-4b-in-annual-revenue/ 2023-07-06T08:21:52+00:00 https://old.journalforclinicalstudies.com/bristol-myers-dominates-list-of-the-most-seen-asco-display-ads-muscling-out-merck-and-pfizer/ 2023-06-29T08:53:53+00:00 https://old.journalforclinicalstudies.com/regenerons-high-dose-eylea-hit-with-surprise-fda-rejection-over-manufacturing-hiccups/ 2023-06-29T08:47:07+00:00 https://old.journalforclinicalstudies.com/after-emergents-rise-and-fall-ceo-robert-kramer-announces-retirement/ 2023-06-29T08:45:04+00:00 https://old.journalforclinicalstudies.com/lilly-forks-over-2-4m-to-settle-federal-agencys-age-discrimination-lawsuit/ 2023-06-29T08:41:23+00:00 https://old.journalforclinicalstudies.com/as-adderall-shortages-persist-takedas-rival-vyvanse-is-now-in-short-supply/ 2023-06-22T09:01:28+00:00 https://old.journalforclinicalstudies.com/needle-free-vaccine-maker-vaxxas-opens-new-manufacturing-facility-hq-in-australia/ 2023-06-22T09:00:23+00:00 https://old.journalforclinicalstudies.com/cdc-advisory-panel-examines-gsk-and-pfizer-rsv-vaccines-set-to-vote-today-on-recommended-use/ 2023-06-22T08:59:29+00:00 https://old.journalforclinicalstudies.com/merck-consolidates-new-jersey-operations-at-reimagined-headquarters-in-rahway/ 2023-06-22T08:58:36+00:00 https://old.journalforclinicalstudies.com/glance-in-the-future-explore-innovative-solutions-at-pharmap-2023/ 2023-06-15T09:56:18+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/06/Pharmap-JCS.jpg https://old.journalforclinicalstudies.com/sanofi-goes-all-in-on-ai-with-new-app-to-support-companys-manufacturing-rd-and-more/ 2023-06-15T08:38:45+00:00 https://old.journalforclinicalstudies.com/biomarins-hemophilia-gene-therapy-may-have-a-chance-at-winning-over-europe-analysts/ 2023-06-15T08:37:29+00:00 https://old.journalforclinicalstudies.com/prokidney-drops-25-5m-on-north-carolina-manufacturing-site-for-cell-therapy-prospect/ 2023-06-15T08:36:03+00:00 https://old.journalforclinicalstudies.com/fda-clears-braeburns-long-acting-brixadi-to-treat-opioid-use-disorder/ 2023-05-25T10:00:40+00:00 https://old.journalforclinicalstudies.com/innoviva-subsidiary-entasis-scores-fda-nod-for-bacterial-pneumonia-combo-drug-xacduro/ 2023-05-25T09:57:23+00:00 https://old.journalforclinicalstudies.com/viatris-scouts-for-new-board-chair-as-longtime-leader-robert-coury-transitions-to-advisory-role/ 2023-05-25T09:50:56+00:00 https://old.journalforclinicalstudies.com/the-clocks-ticking-on-stelara-amgen-jj-ink-patent-settlement/ 2023-05-25T09:47:10+00:00 https://old.journalforclinicalstudies.com/intercepts-latest-nash-bid-in-jeopardy-after-fda-questions-drugs-efficacy-safety/ 2023-05-18T08:47:28+00:00 https://old.journalforclinicalstudies.com/does-ftc-attempt-to-block-amgens-horizon-buy-spell-trouble-for-pfizer-seagen-not-necessarily-analysts-say/ 2023-05-18T08:46:23+00:00 https://old.journalforclinicalstudies.com/regulatory-tracker-another-china-made-pd-1-starts-fda-journey-as-elevar-hengrui-target-big-cancer-type/ 2023-05-18T08:45:23+00:00 https://old.journalforclinicalstudies.com/allergans-new-skin-smoothing-product-gets-fda-nod-with-novel-delivery-mechanism/ 2023-05-18T08:44:29+00:00 https://old.journalforclinicalstudies.com/deepintent-roku-pitch-silver-streamers-as-golden-opportunity-for-pharma-ad-campaigns/ 2023-05-18T08:43:36+00:00 https://old.journalforclinicalstudies.com/the-pharmaceutical-manufacturing-and-packaging-congress-pharmap-2023-2/ 2023-05-11T13:25:29+00:00 https://old.journalforclinicalstudies.com/elrig-uk-appoints-nick-clare-to-board-as-vendor-strategy-work-group-lead/ 2023-05-11T11:00:47+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/05/Nick-Clare.jpg https://old.journalforclinicalstudies.com/roches-plant-decommissioning-costs-in-ireland-climb-to-e57m-plus-reports/ 2023-05-11T08:53:53+00:00 https://old.journalforclinicalstudies.com/novartis-targets-underserved-fields-and-car-t-for-next-phase-of-immunology-growth-exec/ 2023-05-11T08:53:01+00:00 https://old.journalforclinicalstudies.com/perrigos-otc-birth-control-pill-aces-fda-expert-meeting/ 2023-05-11T08:48:33+00:00 https://old.journalforclinicalstudies.com/teva-ceo-richard-francis-after-4-months-at-the-helm-preps-grand-strategic-reveal/ 2023-05-11T08:46:55+00:00 https://old.journalforclinicalstudies.com/beating-its-rivals-gsk-nabs-world-first-approval-for-adult-rsv-vaccine-arexvy/ 2023-05-04T08:23:00+00:00 https://old.journalforclinicalstudies.com/as-amgens-revenues-slide-so-too-do-sales-at-its-big-buyout-target-horizon/ 2023-05-04T08:21:52+00:00 https://old.journalforclinicalstudies.com/immunogen-touts-home-run-as-ovarian-cancer-drug-elahere-extends-lives-in-landmark-trial-win/ 2023-05-04T08:19:41+00:00 https://old.journalforclinicalstudies.com/abbvie-says-botox-rival-revance-recruited-its-employees-in-bid-to-steal-trade-secrets/ 2023-05-04T08:18:22+00:00 https://old.journalforclinicalstudies.com/the-pharmaceutical-manufacturing-and-packaging-congress-pharmap-2023/ 2023-05-03T10:59:08+00:00 https://old.journalforclinicalstudies.com/catch-up-with-pharmap-2023-pharmaceutical-challenges-and-strategies/ 2023-05-03T10:56:36+00:00 https://old.journalforclinicalstudies.com/bristol-myers-giovanni-caforio-to-hand-ceo-baton-to-commercial-chief-chris-boerner/ 2023-04-27T08:20:34+00:00 https://old.journalforclinicalstudies.com/fda-approves-first-oral-microbiome-therapy-vowst-will-nestle-be-around-to-help-seres-with-the-launch/ 2023-04-27T08:17:58+00:00 https://old.journalforclinicalstudies.com/after-shutting-down-akorn-recalls-its-70-plus-products-nationwide/ 2023-04-27T08:16:26+00:00 https://old.journalforclinicalstudies.com/fda-argues-astrazeneca-mercks-lynparza-only-works-in-subset-of-prostate-cancer-patients/ 2023-04-27T08:14:26+00:00 https://old.journalforclinicalstudies.com/pharmaceutical-industry-needs-more-cross-sector-collaboration/ 2023-04-24T09:59:54+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/04/CIPentrance1690x900px.png https://old.journalforclinicalstudies.com/pci-pharma-services-announces-new-sterile-fill-finish-capabilities-now-available-in-melbourne-and-san-diego/ 2023-04-20T08:51:11+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/04/Microcell-1.jpg https://old.journalforclinicalstudies.com/with-hard-fought-polivy-approval-roche-looks-to-shake-up-decades-of-established-practice-in-lymphoma/ 2023-04-20T08:48:04+00:00 https://old.journalforclinicalstudies.com/alnylam-intra-cellular-among-analysts-top-picks-for-ma-as-biopharma-dealmaking-heats-up/ 2023-04-20T08:46:39+00:00 https://old.journalforclinicalstudies.com/gsk-faces-strike-threat-in-uk-again-after-workers-pan-pay-raise/ 2023-04-20T08:45:04+00:00 https://old.journalforclinicalstudies.com/newly-merged-manufacturers-meridian-kindeva-invest-100m-in-missouri-site/ 2023-04-13T08:54:01+00:00 https://old.journalforclinicalstudies.com/takeda-hit-with-another-pay-for-delay-lawsuit-this-time-on-gout-drug-colcrys/ 2023-04-13T08:52:04+00:00 https://old.journalforclinicalstudies.com/astellas-takes-340m-charge-on-evrenzo-joins-gsk-in-nixing-cell-therapy-collab-with-adaptimmune/ 2023-04-13T08:49:40+00:00 https://old.journalforclinicalstudies.com/moderna-nabs-a-win-in-arbutus-patent-case-as-appeals-court-upholds-prior-invalidation/ 2023-04-13T08:47:37+00:00 https://old.journalforclinicalstudies.com/takeda-gets-fda-expansion-of-hyqvia-to-treat-kids-with-primary-immunodeficiency/ 2023-04-13T08:42:07+00:00 https://old.journalforclinicalstudies.com/after-drug-rejection-vanda-scores-courtroom-win-over-fda-in-records-case/ 2023-03-30T08:49:52+00:00 https://old.journalforclinicalstudies.com/pharmaron-snares-uk-grant-to-scale-out-cell-and-gene-facility-it-bought-from-abbvie/ 2023-03-30T08:46:50+00:00 https://old.journalforclinicalstudies.com/boehringer-ingelheim-and-eli-lillys-jardiance-gets-big-lift-from-heart-failure-indications/ 2023-03-30T08:45:21+00:00 https://old.journalforclinicalstudies.com/viatris-cipla-and-aurobindo-sign-up-to-make-generics-of-gsks-long-acting-hiv-prep-drug/ 2023-03-30T08:41:58+00:00 https://old.journalforclinicalstudies.com/no-holes-to-poke-intra-cellulars-caplyta-delivers-sweeping-win-in-depression-trial/ 2023-03-30T08:40:46+00:00 https://old.journalforclinicalstudies.com/critical-considerations-when-designing-shipper-solutions-for-clinical-trials/ 2023-03-29T14:37:13+00:00 https://old.journalforclinicalstudies.com/assent-is-not-just-for-children/ 2023-03-29T14:36:39+00:00 https://old.journalforclinicalstudies.com/mrna-vaccine-applications-in-global-health-promise-and-challenges/ 2023-03-29T14:36:13+00:00 https://old.journalforclinicalstudies.com/central-europe-look-behind-the-curtain-of-trials-for-on-the-ground-knowledge/ 2023-03-29T14:35:47+00:00 https://old.journalforclinicalstudies.com/the-future-of-clinical-research-in-ukraine/ 2023-03-29T14:35:17+00:00 https://old.journalforclinicalstudies.com/learning-from-the-past/ 2023-03-29T14:34:48+00:00 https://old.journalforclinicalstudies.com/beyond-pill-count-challenging-the-status-quo-for-medication-adherence-in-clinical-trials/ 2023-03-29T14:34:13+00:00 https://old.journalforclinicalstudies.com/improving-clinical-study-publishing-success/ 2023-03-29T14:33:47+00:00 https://old.journalforclinicalstudies.com/taking-a-long-term-approach-to-improving-vaccine-trial-recruitment/ 2023-03-29T14:33:12+00:00 https://old.journalforclinicalstudies.com/impact-of-electronic-signature-towards-clinical-trial-agreements/ 2023-03-29T14:32:47+00:00 https://old.journalforclinicalstudies.com/recent-fda-advancements-in-rare-diseases-funding-partnerships-and-programs/ 2023-03-29T14:32:21+00:00 https://old.journalforclinicalstudies.com/novartis-coherus-pd-1-drugs-finally-set-for-fda-manufacturing-inspections-after-covid-delays/ 2023-03-23T09:36:06+00:00 https://old.journalforclinicalstudies.com/after-appeals-loss-johnson-johnson-will-take-texas-two-step-case-to-the-us-supreme-court/ 2023-03-23T09:34:03+00:00 https://old.journalforclinicalstudies.com/gsk-eyeing-new-blockbuster-market-taps-magic-johnson-to-raise-rsv-awareness-ahead-of-pfizer-faceoff/ 2023-03-23T09:32:13+00:00 https://old.journalforclinicalstudies.com/in-a-surprise-approval-fda-green-lights-incytes-pd-1-inhibitor-to-treat-rare-cancer-type/ 2023-03-23T09:30:47+00:00 https://old.journalforclinicalstudies.com/chasing-pfizer-gsks-5-in-1-meningococcal-vaccine-delivers-phase-3-trial-win/ 2023-03-15T10:21:41+00:00 https://old.journalforclinicalstudies.com/novo-nordisk-follows-eli-lillys-lead-slashing-insulin-prices-in-the-us/ 2023-03-15T10:20:45+00:00 https://old.journalforclinicalstudies.com/in-industrywide-price-fixing-case-sun-pharma-opts-to-settle-for-75m/ 2023-03-15T10:16:21+00:00 https://old.journalforclinicalstudies.com/nonprofit-hospitals-tax-exemptions-paid-off-big-once-covid-relief-began-flowing-in/ 2023-03-15T10:12:50+00:00 https://old.journalforclinicalstudies.com/cms-not-likely-to-follow-the-vas-example-and-cover-alzheimers-medication-lecanemab-say-experts/ 2023-03-15T10:11:37+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-expands-biologics-leadership-with-new-center-of-excellence-facility-in-the-midwest/ 2023-03-14T15:10:46+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2023/03/PCI-ResourceCardBG-TECH-Red-AutoInjector-v2-2.jpg https://old.journalforclinicalstudies.com/covis-finally-pulls-preterm-birth-drug-makena-after-12-year-accelerated-approval-odyssey/ 2023-03-09T09:41:12+00:00 https://old.journalforclinicalstudies.com/novo-nordisks-popular-weight-loss-drug-wegovy-set-for-uk-launch-after-cost-watchdogs-blessing/ 2023-03-09T09:39:29+00:00 https://old.journalforclinicalstudies.com/amid-major-restructuring-novartis-ceo-vas-narasimhans-2022-pay-fell-by-more-than-a-quarter/ 2023-03-09T09:37:46+00:00 https://old.journalforclinicalstudies.com/will-the-fda-investigate-gsk-over-zantac-delauro-wants-to-know/ 2023-03-09T09:36:53+00:00 https://old.journalforclinicalstudies.com/abbvies-skyrizi-tops-the-charts-for-februarys-leading-tv-drug-ad-spenders-as-pfizers-paxlovid-makes-its-entrance/ 2023-03-09T09:33:21+00:00 https://old.journalforclinicalstudies.com/trilogy/ 2023-03-02T10:56:49+00:00 https://old.journalforclinicalstudies.com/icer-dials-up-recommended-price-range-for-eisais-leqembi-but-still-calls-for-sizable-discount/ 2023-03-02T09:35:16+00:00 https://old.journalforclinicalstudies.com/johnson-johnson-logs-57-layoffs-in-pennsylvania-as-kenvue-spinoff-nears/ 2023-03-02T09:33:10+00:00 https://old.journalforclinicalstudies.com/regeneron-sanofis-kevzara-becomes-first-biologic-approved-for-polymyalgia-rheumatica/ 2023-03-02T09:31:40+00:00 https://old.journalforclinicalstudies.com/roche-sues-biogen-over-royalties-related-to-multiple-sclerosis-drug-tysabri/ 2023-03-02T09:29:12+00:00 https://old.journalforclinicalstudies.com/gilead-teva-and-jjs-hiv-antitrust-case-inches-closer-to-trial-as-judge-keeps-most-claims-on-the-table/ 2023-02-23T09:41:02+00:00 https://old.journalforclinicalstudies.com/in-reorganization-bayer-lays-off-55-at-berkeley-california-campus/ 2023-02-23T09:39:16+00:00 https://old.journalforclinicalstudies.com/in-heavyweight-clash-gsks-long-acting-hiv-injectable-matches-gileads-top-drug-biktarvy/ 2023-02-23T09:37:51+00:00 https://old.journalforclinicalstudies.com/eli-lillys-diabetes-drug-mounjaro-back-in-stock-amid-heightened-obesity-interest/ 2023-02-23T09:36:32+00:00 https://old.journalforclinicalstudies.com/catalyst-clinical-research/ 2023-02-22T11:09:10+00:00 https://old.journalforclinicalstudies.com/grifols-jumps-pharmas-2023-layoff-queue-with-plans-to-scrap-2300-jobs-primarily-in-the-us/ 2023-02-16T09:21:30+00:00 https://old.journalforclinicalstudies.com/after-jjs-texas-two-step-stumble-another-talc-plaintiff-heads-to-trial-report/ 2023-02-16T09:19:24+00:00 https://old.journalforclinicalstudies.com/gsk-was-warned-repeatedly-about-zantac-impurity-but-played-down-risks-bloomberg/ 2023-02-16T09:18:06+00:00 https://old.journalforclinicalstudies.com/biogen-chairman-to-step-down-as-new-ceo-walks-thin-line-with-alzheimers-launch-leqembi/ 2023-02-16T09:15:39+00:00 https://old.journalforclinicalstudies.com/looking-forward-to-humira-biosimilar-launch-teva-leans-on-ajovy-and-austedo-as-revenues-sink/ 2023-02-09T10:07:22+00:00 https://old.journalforclinicalstudies.com/vertex-teases-launch-plans-for-first-crispr-gene-editing-therapy-ahead-of-fda-decision/ 2023-02-09T10:05:20+00:00 https://old.journalforclinicalstudies.com/pharma-sings-for-its-supper-as-astrazeneca-eli-lilly-pfizer-and-more-spend-big-on-drug-ads-at-the-grammys/ 2023-02-09T10:03:39+00:00 https://old.journalforclinicalstudies.com/bayer-taps-roche-vet-anderson-as-its-next-ceo-pushing-out-baumann/ 2023-02-09T10:02:56+00:00 https://old.journalforclinicalstudies.com/bristol-myers-squibb-debuts-first-spot-for-sotyktu-during-the-grammys/ 2023-02-09T10:01:10+00:00 https://old.journalforclinicalstudies.com/after-trial-flop-eu-officials-take-a-closer-look-at-novartis-adakveo-approval/ 2023-01-31T09:18:18+00:00 https://old.journalforclinicalstudies.com/menarini-shows-big-pharma-how-its-done-with-first-approval-for-oral-serd-drug-in-breast-cancer/ 2023-01-31T09:14:27+00:00 https://old.journalforclinicalstudies.com/sanofi-offers-retirement-scheme-to-hundreds-of-staffers-at-2-indian-vaccine-plants/ 2023-01-31T09:12:43+00:00 https://old.journalforclinicalstudies.com/court-rejects-johnson-johnsons-texas-two-step-bankruptcy-ploy-for-talc-claims/ 2023-01-31T09:11:34+00:00 https://old.journalforclinicalstudies.com/bms-settles-lawsuit-with-two-fired-employees-who-refused-covid-vaccines/ 2023-01-31T09:10:30+00:00 https://old.journalforclinicalstudies.com/moderna-now-in-the-crosshairs-of-sens-warren-welch-over-price-tag-for-covid-vaccine/ 2023-01-26T09:53:10+00:00 https://old.journalforclinicalstudies.com/mercks-keytruda-dealt-another-blow-in-prostate-cancer-but-readies-new-challenge-to-azs-imfinzi/ 2023-01-26T09:51:55+00:00 https://old.journalforclinicalstudies.com/as-scangos-bids-adieu-vir-taps-bayer-dealmaker-de-backer-as-its-next-ceo/ 2023-01-26T09:48:54+00:00 https://old.journalforclinicalstudies.com/in-flux-cdmo-abzena-lays-off-66-in-san-diego-days-after-hiring-new-ceo-and-reshuffling-board/ 2023-01-26T09:47:31+00:00 https://old.journalforclinicalstudies.com/health-group-lambasts-novo-nordisk-for-paid-news-program-on-weight-loss-med-wegovy/ 2023-01-26T09:46:22+00:00 https://old.journalforclinicalstudies.com/abbvie-novartis-and-more-win-national-coverage-in-china-even-as-pfizers-paxlovid-gets-left-out/ 2023-01-19T09:28:12+00:00 https://old.journalforclinicalstudies.com/chinas-genscript-conjures-224m-in-investor-cash-for-its-biologics-contractor-probio/ 2023-01-19T09:26:46+00:00 https://old.journalforclinicalstudies.com/fda-fires-back-at-conservative-groups-lawsuit-over-abortion-pill-approval/ 2023-01-19T09:25:47+00:00 https://old.journalforclinicalstudies.com/servier-taiho-score-in-phase-3-colorectal-cancer-trial-to-support-lonsurf-combo-nod/ 2023-01-19T09:25:02+00:00 https://old.journalforclinicalstudies.com/cdc-probes-possible-safety-risk-for-pfizers-new-covid-shot-sees-no-need-to-change-vaccine-practices/ 2023-01-19T09:23:49+00:00 https://old.journalforclinicalstudies.com/is-gsks-15-day-accelerated-approval-withdrawal-the-new-normal-hear-fda-commissioner-califfs-response/ 2023-01-12T10:18:33+00:00 https://old.journalforclinicalstudies.com/amid-launch-spree-eli-lilly-expects-revenue-growth-at-the-high-end-of-the-industry-cfo-says/ 2023-01-12T10:16:50+00:00 https://old.journalforclinicalstudies.com/lilly-biogen-and-more-gear-up-for-blockbuster-launches-in-2023-report/ 2023-01-12T10:15:30+00:00 https://old.journalforclinicalstudies.com/astrazenecas-first-in-class-rescue-inhaler-airsupra-wins-fda-nod-but-only-for-adult-use/ 2023-01-12T10:13:40+00:00 https://old.journalforclinicalstudies.com/pocn-creates-hiv-center-of-excellence-learning-hub-for-nps-and-pas/ 2023-01-12T10:12:34+00:00 https://old.journalforclinicalstudies.com/pfizer-wins-again-in-courtroom-fight-versus-astellas-over-lexiscan-patents/ 2023-01-05T09:58:29+00:00 https://old.journalforclinicalstudies.com/amgen-garners-wide-support-from-pharma-peers-in-supreme-court-patent-fight-with-sanofi/ 2023-01-05T09:57:07+00:00 https://old.journalforclinicalstudies.com/novartis-pays-245m-to-settle-exforge-generic-pay-for-delay-lawsuit/ 2023-01-05T09:54:50+00:00 https://old.journalforclinicalstudies.com/biogen-fdas-inappropriate-aduhelm-coordination-detailed-in-blistering-congressional-report/ 2023-01-05T09:53:13+00:00 https://old.journalforclinicalstudies.com/new-online-certified-course-gain-expertise-in-gmp-for-medical-devices-and-fda-21-cfr-part-820/ 2022-12-15T13:12:23+00:00 https://old.journalforclinicalstudies.com/antibiotics-pro-centrient-runs-afoul-of-fda-at-indian-manufacturing-plant/ 2022-12-15T09:59:40+00:00 https://old.journalforclinicalstudies.com/novartis-busy-with-its-restructuring-sells-5-eye-drugs-for-up-to-175m/ 2022-12-15T09:56:17+00:00 https://old.journalforclinicalstudies.com/court-swats-down-vandas-patent-suit-against-teva-and-apotex-clearing-the-way-for-hetlioz-generics/ 2022-12-15T09:55:09+00:00 https://old.journalforclinicalstudies.com/merck-roche-and-jj-among-pharma-players-weighing-russian-operations-amid-humanitarian-tightrope-walk/ 2022-12-13T17:34:30+00:00 https://old.journalforclinicalstudies.com/fierce-pharma-asia-eisais-oncology-unit-cut-wuxi-samsung-expansions-beigene-novartis-pd-1-pivot/ 2022-12-13T17:22:32+00:00 https://old.journalforclinicalstudies.com/paediatric-melanoma-pharmaceutical-industry/ 2022-12-13T17:17:20+00:00 https://old.journalforclinicalstudies.com/highlights-from-the-fiped-global-education-report/ 2022-12-07T15:57:25+00:00 https://old.journalforclinicalstudies.com/curricula-then-and-now-an-environmental-scan-and-recommendations/ 2022-12-07T15:54:08+00:00 https://old.journalforclinicalstudies.com/jj-bows-out-of-horizon-bid-as-amgen-and-sanofi-eye-cash-plays-for-rare-disease-drugmaker/ 2022-12-07T11:39:40+00:00 https://old.journalforclinicalstudies.com/pfizer-biontech-strike-back-at-moderna-with-mrna-vaccine-patent-lawsuit/ 2022-12-07T11:37:44+00:00 https://old.journalforclinicalstudies.com/abbvies-rinvoq-retakes-the-crown-from-sanofis-dupixent-as-the-top-tv-drug-ad-spender-in-november/ 2022-12-07T11:36:32+00:00 https://old.journalforclinicalstudies.com/emergent-snags-speedy-fda-review-potentially-teeing-up-over-the-counter-narcan-by-next-spring/ 2022-12-07T11:35:28+00:00 https://old.journalforclinicalstudies.com/sabcs-lilly-aims-verzenio-at-broader-post-surgery-breast-cancer-nod-as-novartis-rival-draws-near-will-fda-bite/ 2022-12-07T11:34:26+00:00 https://old.journalforclinicalstudies.com/pci-clinicalsmart-a-smart-solution-to-clinical-supply-management/ 2022-11-30T15:19:06+00:00 https://old.journalforclinicalstudies.com/how-digital-health-can-reshape-pharmas-hole-in-healthcare/ 2022-11-30T15:18:33+00:00 https://old.journalforclinicalstudies.com/optimising-trials-assessing-cognitive-post-acute-sequelae-of-sars-cov-2-infection-pasc-cog/ 2022-11-30T15:17:59+00:00